Page 1087 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

31. Melanson M, et al. Varicella-zoster virus DNA in CSF and 51. Singh N, Paterson DL. Encephalitis caused by human herpesvi-
arteries in delayed contralateral hemiplegia: evidence for viral rus-6 in transplant recipients: relevance of a novel neurotropic
invasion of cerebral arteries. Neurology. 1996;47(2):569-570. virus. Transplantation. 2000;69(12):2474-2479.
32. Hilt DC, et al. Herpes zoster ophthalmicus and delayed contra- 52. Isaacson E, et al. Evidence of human herpesvirus 6 infection in
lateral hemiparesis caused by cerebral angiitis: diagnosis and 4 immunocompetent patients with encephalitis. Clin Infect Dis.
management approaches. Ann Neurol. 1983;14(5):543-553. 2005;40(6):890-893.
33. Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH. 53. Suga S, et al. IgM neutralizing antibody responses to human
The patterns of varicella zoster virus encephalitis. Hum Pathol. herpesvirus-6 in patients with exanthem subitum or organ
1996;27(9):927-938. transplantation. Microbiol Immunol. 1992;36(5):495-506.
34. Steiner I, et al. Spinal cord involvement in uncomplicated 54. Weigler BJ. Biology of B virus in macaque and human hosts: a
herpes zoster. Clin Diagn Lab Immunol. 2001;8(4):850-851. review. Clin Infect Dis. 1992;14(2):555-567.
35. Gilden D. Varicella zoster virus and central nervous system 55. Holmes GP, et al. B virus (Herpesvirus simiae) infection in
syndromes. Herpes. 2004;11(suppl 2):89A-94A. humans: epidemiologic investigation of a cluster. Ann Intern
36. Drew WL. Cytomegalovirus disease in the highly active antiret- Med. 1990;112(11):833-839.
roviral therapy era. Curr Infect Dis Rep. 2003;5(3):257-265. 56. Cohen JI, et al. Recommendations for prevention of and therapy
37. Maschke M, et al. Opportunistic CNS infection after for exposure to B virus (cercopithecine herpesvirus 1). Clin
bone marrow transplantation. Bone Marrow Transplant. Infect Dis. 2002;35(10):1191-1203.
1999;23(11):1167-1176. 57. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet.
38. Maschke M, Kastrup O, Diener HC. CNS manifestations of 2008;371(9611):500-509.
cytomegalovirus infections: diagnosis and treatment. CNS 58. Campbell GL, et al. West Nile virus. Lancet Infect Dis.
Drugs. 2002;16(5):303-315. 2002;2(9):519-529.
39. Clifford DB, et al. Magnetic resonance brain imaging lacks 59. Hayes EB, et al. Virology, pathology, and clinical manifestations of
sensitivity for AIDS associated cytomegalovirus encephalitis. West Nile virus disease. Emerg Infect Dis. 2005;11(8):1174-1179.
J Neurovirol. 1996;2(6):397-403. 60. Ali M, et al. West Nile virus infection: MR imaging findings in the
40. Burke DG, et al. The utility of clinical and radiographic features nervous system. AJNR Am J Neuroradiol. 2005;26(2):289-297.
in the diagnosis of cytomegalovirus central nervous system 61. Rossi, SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med.
disease in AIDS patients. Mol Diagn. 1999;4(1):37-43. 2010;30(1):47-65.
41. Clifford DB, et al. Use of polymerase chain reaction to dem- 62. Diagana M, Preux PM, Dumas M. Japanese encephalitis
onstrate cytomegalovirus DNA in CSF of patients with human revisited. J Neurol Sci. 2007;262(1-2):165-170.
immunodeficiency virus infection. Neurology. 1993;43(1):75-79.
63. Kumar R, et al. Clinical features & prognostic indicators of
42. Morgello S, et al. Cytomegalovirus encephalitis in patients Japanese encephalitis in children in Lucknow (India). Indian J
with acquired immunodeficiency syndrome: an autopsy Med Res. 1990;91:321-327.
study of 30 cases and a review of the literature. Hum Pathol.
1987;18(3):289-297. 64. Kumar S, et al. MRI in Japanese encephalitis. Neuroradiology.
1997;39(3):180-184.
43. Studahl M, et al. Cytomegalovirus encephalitis in four immuno-
competent patients. Lancet. 1992;340(8826):1045-1046. 65. Davis LE, Beckham JD, Tyler KL. North American encephalitic
arboviruses. Neurol Clin. 2008;26(3):727-757, ix.
44. Griffiths P. Cytomegalovirus infection of the central nervous
system. Herpes. 2004;11(suppl 2):95A-104A. 66. Rahal JJ, et al. Effect of interferon-alpha2b therapy on St. Louis
viral meningoencephalitis: clinical and laboratory results of a
45. Silverstein A, Steinberg G, Nathanson M. Nervous system pilot study. J Infect Dis. 2004;190(6):1084-1087.
involvement in infectious mononucleosis. The heralding and-or
major manifestation. Arch Neurol. 1972;26(4):353-358. 67. Centers for Disease Control and Prevention (CDC). Outbreak
of Powassan encephalitis–Maine and Vermont, 1999-2001.
46. Davies NW, et al. Factors influencing PCR detection of viruses MMWR Morb Mortal Wkly Rep. 2001;50(35):761-764.
in cerebrospinal fluid of patients with suspected CNS infections.
J Neurol Neurosurg Psychiatry. 2005;76(1):82-87. 68. Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am.
2008;22(3):561-575, x.
47. Tunkel AR, et al. The management of encephalitis: clinical prac-
tice guidelines by the Infectious Diseases Society of America. 69. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet.
Clin Infect Dis. 2008;47(3):303-327. 2008;371(9627):1861-1871.
48. MacGinley R, et al. Epstein-Barr virus encephalitis in a renal 70. Lum LC, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr.
allograft recipient diagnosed by polymerase chain reaction on 1998;133(6):795-798.
cerebrospinal fluid and successfully treated with ganciclovir. 71. Huang CC, et al. Neurologic complications in children with
Nephrol Dial Transplant. 2001;16(1):197-198. enterovirus 71 infection. N Engl J Med. 1999;341(13):936-942.
49. Okuno T, et al. Seroepidemiology of human herpesvirus 6 72. McKinney RE, Jr., Katz SL, Wilfert CM. Chronic enteroviral
infection in normal children and adults. J Clin Microbiol. meningoencephalitis in agammaglobulinemic patients. Rev
1989;27(4):651-653. Infect Dis. 1987;9(2):334-356.
50. Drobyski WR, et al. Brief report: fatal encephalitis due to variant 73. Hollidge BS, Gonzalez-Scarano F, Soldan SS. Arboviral
B human herpesvirus-6 infection in a bone marrow-transplant encephalitides: transmission, emergence, and pathogenesis.
recipient. N Engl J Med. 1994;330(19):1356-1360. J Neuroimmune Pharmacol. 2010;5(3):428-442.

Section05-O-ref.indd 2 1/20/2015 4:51:23 PM